TY - JOUR
T1 - Priming of platelet α(IIb)β3 by oxidants is associated with tyrosine phosphorylation of β3
AU - Irani, Kaikobad
AU - Pham, Youm
AU - Coleman, Lindsay D.
AU - Roos, Christine
AU - Cooke, Glen E.
AU - Miodovnik, Amir
AU - Karim, Nayeem
AU - Wilhide, Calvin C.
AU - Bray, Paul F.
AU - Goldschmidt-Clermont, Pascal J.
PY - 1998
Y1 - 1998
N2 - Reactive oxygen species play an important role at the site of vascular injuries and arterial thromboses. We studied the mechanism mediating platelet aggregation induced by H2O2, a major cellular oxidant. Exposure to H2O2 triggered platelet aggregation, but only when the platelets were stirred. Strong platelet aggregation induced by H2O2 required the presence of the tyrosine phosphatase inhibitor sodium orthovanadate (NaVO4) and was dependent on the participation of integrin α(IIb)β3 (glycoprotein IIb- IIIa). A specific inhibitor of α(IIb)β3 blocked platelet aggregation induced by H2O2 and NaVO4, thus confirming that aggregation requires this receptor. In the presence of H2O2 and NaVO4, multiple platelet substrates were phosphorylated on tyrosine. Such tyrosine kinase response was necessary but not sufficient to activate α(IIb)β3, as detected by binding of soluble fibrinogen to platelets. Stirring of the platelets exposed to H2O2 and NaVO4 was also needed to allow for binding of fibrinogen to α(IIb)β3. The tyrosine kinase inhibitor genistein was able to block platelet aggregation induced by H2O2 and NaVO4, thus confirming that tyrosine kinase activity was needed to trigger α(IIb)β3 activation on stirring. N-Acetyl-L-cysteine, a cell-permeant antioxidant, blocked the tyrosine phosphorylation of platelet substrates and also the platelet aggregation induced by H2O2 and NaVO4. We found that β3 was phosphorylated on tyrosine in platelets exposed to H2O2 and NaVO4, even in the absence of aggregation. Hence, tyrosine phosphorylation of β3 might contribute to the 'priming' of α(IIb)β3 induced by H2O2 and NaVO4, whereby the receptor can become activated on stirring of the platelets.
AB - Reactive oxygen species play an important role at the site of vascular injuries and arterial thromboses. We studied the mechanism mediating platelet aggregation induced by H2O2, a major cellular oxidant. Exposure to H2O2 triggered platelet aggregation, but only when the platelets were stirred. Strong platelet aggregation induced by H2O2 required the presence of the tyrosine phosphatase inhibitor sodium orthovanadate (NaVO4) and was dependent on the participation of integrin α(IIb)β3 (glycoprotein IIb- IIIa). A specific inhibitor of α(IIb)β3 blocked platelet aggregation induced by H2O2 and NaVO4, thus confirming that aggregation requires this receptor. In the presence of H2O2 and NaVO4, multiple platelet substrates were phosphorylated on tyrosine. Such tyrosine kinase response was necessary but not sufficient to activate α(IIb)β3, as detected by binding of soluble fibrinogen to platelets. Stirring of the platelets exposed to H2O2 and NaVO4 was also needed to allow for binding of fibrinogen to α(IIb)β3. The tyrosine kinase inhibitor genistein was able to block platelet aggregation induced by H2O2 and NaVO4, thus confirming that tyrosine kinase activity was needed to trigger α(IIb)β3 activation on stirring. N-Acetyl-L-cysteine, a cell-permeant antioxidant, blocked the tyrosine phosphorylation of platelet substrates and also the platelet aggregation induced by H2O2 and NaVO4. We found that β3 was phosphorylated on tyrosine in platelets exposed to H2O2 and NaVO4, even in the absence of aggregation. Hence, tyrosine phosphorylation of β3 might contribute to the 'priming' of α(IIb)β3 induced by H2O2 and NaVO4, whereby the receptor can become activated on stirring of the platelets.
KW - Glycoprotein IIb- IIIa
KW - Platelets
KW - Reactive oxygen species
KW - Shear
KW - Tyrosine kinases
UR - http://www.scopus.com/inward/record.url?scp=17344370149&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17344370149&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.18.11.1698
DO - 10.1161/01.ATV.18.11.1698
M3 - Article
C2 - 9812907
AN - SCOPUS:17344370149
SN - 1079-5642
VL - 18
SP - 1698
EP - 1706
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 11
ER -